Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 9016-9024

  Dawson, Christopher W ^a   Dawson, Joanne ^a   Jones, Richard ^a   Ward, Kim ^a   Young, Lawrence S ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

EID: 0031656672     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.9016-9024.1998     Document Type: Article

References (52)

1. Adams, J. C., and F. M. Watt. 1989. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340:307-309.
2. Boise, L. H., M. Gonzalezgarcia, C. E. Postema, L. Y. Ding, T. Lindsten, L. A. Turka, X. H. Mao, G. Nunez, and C. B. Thompson. 1993. Bcl-X, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
3. Borner, C. 1996. Diminished cell-proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 271:12695-12698.
4. L and Bcl-2. EMBO J. 16:968-977.
5. Cheng, E. H.-Y., J. Nicholas, D. S. Bellows, G. S. Hayward, H.-G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi's sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690-694.
6. Cleary, M. L., S. D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14-18) translocation. Cell 47:19-28.
7. Dawson, C. W., A. B. Rickinson, and L. S. Young. 1990. Epstein-Barr-virus latent membrane-protein inhibits human epithelial-cell differentiation. Nature 344:777-780.
8. Dawson, C. W., A. G. Eliopoulos, J. Dawson, and L. S. Young. 1995. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene 9:69-77.
9. Fernandez-Sarabia, M. J., and J. R. Bischoff. 1993. Bcl-2 associates with the ras-related protein R-Ras p23. Nature 366:274-275.
10. Foghsgaard, L., and M. Jäättelä. 1997. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J. Virol. 71:7509-7517.
11. Frisch, S. M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell. Biol. 124:619-626.
12. Gigi-Leitner, O., B. Geiger, R. Levy, and B. Czernobilsky. 1986. Cytokeratin expression in squamous metaplasia of the uterine cervix. Differentiation 31:191-205.
13. Gilligan, K., P. Rajadurai, L. Resnick, and N. Raab-Traub. 1990. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplasia. Proc. Natl. Acad. Sci. USA 87:8790-8794.
14. Greenspan, J. S., D. Greenspan, E. T. Lennette, D. I. Abrams, M. A. Canant, V. Petersen, and U. K. Freese. 1985. Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313:1564-1571.
15. Harada, H., T. Mitsuyasu, Y. Seta, Y. Maruoka, K. Toyoshima, and S. Yasumoto. 1998. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J. Oral. Pathol. Med. 27:11-17.
16. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
17. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-8483.
18. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961-6965.
19. Horner, D., L. Lewis, and P. J. Farrell. 1995. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers. Intervirology 38:195-205.
20. Huang, D. C. S., L. A. O'Reilly, A. Strasser, and S. Cory. 1997. The antiapoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:4628-4638.
21. Kawanishi, M. 1997. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J. Virol. 71:3319-3322.
22. Khanim, F., C. Dawson, C. A. Meseda, J. Dawson, M. Mackett, and L. S. Young. 1997. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J. Gen. Virol. 78:2987-2999.
23. Kikuchi, K., K. Tsutsumi, Y. Ohta, and S. Yasumoto. 1997. Time correlation of commitment to calcium-induced and terminal differentiation in human ectocervical keratinocytes in suspension cultures. Cell Growth Differ. 8:571-579.
24. Lee, M. A., and J. L. Yates. 1992. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bc12, is not essential for transformation of B cells or for virus replication in vitro. J. Virol. 66:1899-1906.
25. Magrath, I., V. Jain, and K. Bhatia. 1992. Epstein-Barr virus and Burkitt's lymphoma. Semin. Cancer Biol. 3:285-295.
26. Marchini, A., B. Tomkinson, J. I. Cohen, and E. Kieff. 1991. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensible for B-lymphocyte transformation and virus replication. J. Virol. 65:5991-6000.
27. Marthinuss, J., L. Lawrence, and M. Seiberg. 1995. Apoptosis in pam212, an epidermal keratinocyte cell-line: a possible role for bcl-2 in epidermal differentiation. Cell Growth Differ. 6:239-250.
28. Mazel, S., D. Burtrum, and H. T. Petrie. 1996. Regulation of cell-division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell-death. J. Exp. Med. 183:2219-2226.
29. McCall, C. A., and J. J. Cohen. 1991. Programmed cell-death in terminally differentiating keratinocytes: role of endogenous endonuclease. J. Investig. Dermatol. 97:111-114.
30. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
31. Nava, V. E., E. H.-Y. Cheng, M. Veliuona, S. Zou, R. J. Clem, M. L. Mayer, and J. M. Hardwick. 1997. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:4118-4122.
32. Niedobitek, G., L. S. Young, R. Lau, L. Brooks, D. Greenspan, J. S. Greenspan, and A. B. Rickinson. 1991. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J. Gen. Virol. 72:3035-3046.
33. O'Reilly, L. A., D. C. S. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979-6990.
34. Parkinson, E. K., P. Grabham, and A. Emmerson. 1983 A sub-population of cultured human keratinocytes which is resistant to the induction of terminal differentiation-related changes by phorbol, 12-myristate, 13-acetate: evidence for an increase in the resistant population following transformation. Carcinogenesis 4:857-861.
35. Pearson, G. R., J. Luka, L. Petti, J. Sample, M. Birkenbach, D. Braun, and E. Kieff. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160: 151-161.
36. Pietenpol, J. A., N. Papadopoulos, S. Markowitz, J. K. V. Willson, K. W. Kanzler, and B. Vogelstein. 1994. Paradoxical inhibition of solid tumor-cell growth by bc12. Cancer Res. 54:3714-3717.
37. Raab-Traub, N. 1992. Epstein-Barr virus and nasopharyngeal carcinoma. Semin. Cancer Biol. 3:297-307.
38. Rheinwald, J. G., and M. A. Beckett. 1981. Tumourigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
39. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
40. Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and Y. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat. Med. 3:293-298.
41. Shibata, D., and L. M. Weiss. 1992. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 140:769-774.
42. Subramanian, T., J. M. Boyd, and G. Chinnadurai. 1995. Functional substitution identifies a cell survival promoting domain common to adenovirus E1B-19 kDa and Bcl-2 proteins. Oncogene 11:2403-2409.
43. Tarodi, B., T. Subramanian, and G. Chinnadurai. 1994. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201:404-407.
44. Theodorakis, P., C. D'Sa-Eipper, T. Subramanian, and G. Chinnadurai. 1996. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene 12:1707-1713.
45. Thomas, J. A., M. Allday, and D. H. Crawford. 1991. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised disorders. Adv. Cancer Res. 57:329-380.
46. Tsujimoto, Y. 1989. Overexpression of the human Bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA 86:1958-1962.
47. Uhlmann, E. J., C. D'Sa-Eipper, T. Subramanian, A. J. Wagner, N. Hay, and G. Chinnadurai. 1996. Deletion of a nonconserved region of bcl-2 confers a novel gain of function-suppression of apoptosis with concomitant cell-proliferation. Cancer Res. 56:2506.
48. Vairo, G., K. M. Innes, and J. M. Adams. 1996. Bcl-2 has a cell-cycle inhibitory function separable from its enhancement of cell-survival. Oncogene 13:1511-1519.
49. Wang, H. G., J. A. Millan, A. D. Cox, C. J. Der, U. R. Rapp, T. Beck, H. B. Zha, and J. C. Reed. 1995. R-Ras promotes apoptosis caused by growth-factor deprivation via a Bcl-2 suppressible mechanism. J. Cell Biol. 129: 1103-1114.
50. Woodcock-Mitchell, J., R. Eichner, W. G. Nelson, and T. T. Sun. 1982. Immunolocalization of keratin polypeptides in human-epidermis using monoclonal-antibodies. J. Cell Biol. 95:580-588.
51. Young, L. S., K. Lau, M. Rowe, G. Niedobitek, G. Packham, F. Shanaham, D. T. Rowe, D. Greenspan, J. S. Greenspan, A. B. Rickinson, and P. J. Farrell. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.
52. Young, L. S., C. W. Dawson, and A. G. Eliopoulos. 1997. Viruses and apoptosis. Br. Med. Bull. 53:509-521.